Ad
related to: cost plus drugs
Search results
Results from the Tech24 Deals Content Network
Mark Cuban Cost Plus Drug Company ( MCCPDC ), doing business as Cost Plus Drugs, is an American public benefit corporation [ 1] with its main headquarters located in Dallas, Texas. The company is focused on the pharmacy distribution of drugs with a stated goal to lower the prices for generic drugs by removing middlemen and by moving to a cost ...
Cost Plus Drugs’ 22,000-square-foot pharmaceutical facility in Dallas’ Deep Ellum neighborhood originally had been slated for completion in late 2022. Just as important as the drugs themselves ...
Cost Plus Drugs launched its online marketplace in early 2022, with the mission to buy drugs and sell them directly, and thereby more cheaply, to consumers.
The Cost Plus Drug Company aims very simply to provide as many common medications as possible in generic form at as low a price as possible. All cash, no IP deals, no insurance companies — just ...
Cost Plus Drugs is a direct-to-consumer prescription drug company that aims to eliminate middlemen by buying drugs directly from manufacturers and then selling them "at our cost + a fixed 15% margin."
Cost-plus pricing is a pricing strategy by which the selling price of a product is determined by adding a specific fixed percentage (a "markup") to the product's unit cost. Essentially, the markup percentage is a method of generating a particular desired rate of return. [ 1][ 2] An alternative pricing method is value-based pricing.
Working with Oshmyansky, now CEO of Cost Plus Drug Co., the company went online in January, selling generic medications at what it says is a fixed markup of 15%, plus a $3 flat fee. Shipping costs ...
Cuban instead decided to financially back the entire company, and the name was changed to Mark Cuban Cost Plus Drug Company (MCCPDC), or more simply Cost Plus Drugs. [1] Oshmyansky is a staff radiologist at Vision Radiology, for which he performs teleradiology at multiple locations around the United States. [2]
Ad
related to: cost plus drugs